Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CR 6086

Next Previous
Search
Drug Profile

CR 6086

Alternative Names: CR-6086

Latest Information Update: 11 Jul 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Rottapharm Madaus
  • Developer Rottapharm Biotech
  • Class Amides; Amines; Anti-inflammatories; Antineoplastics; Antirheumatics; Aza compounds; Benzoic acids; Cyclopropanes; Fluorocarbons; Small molecules; Spiro compounds
  • Mechanism of Action Prostaglandin E EP4 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Rheumatoid arthritis
  • Phase I/II Colorectal cancer

Most Recent Events

  • 31 May 2024 Efficacy data from a phase I/II trial in Colorectal cancer presented at the 60th Annual Meeting of the American Society of Clinical Oncology (ASCO-2024)
  • 20 Oct 2023 Efficacy and adverse events data from a phase I/II trial in Colorectal cancer presented at the 48th European Society for Medical Oncology Congress 2023 (ESMO 2023)
  • 23 Aug 2023 Phase-I development in Rheumatoid-arthritis (In volunteers) is ongoing in Italy (PO) (Rottapharm Biotech pipeline, August 2023)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top